NFKB1 and non-small cell lung carcinoma: The stratification power of CLR/LDH highlights a potential “inflammatory phenotype” in PD-L1-negative NSCLC, characterized by: ​Constitutive NF-κB activation: Driving IL-6/STAT3 signaling and CRP production (31, 32).